Skip to main content
Premium Trial:

Request an Annual Quote

Layoffs at 23andMe

23andMe has laid off about 100 employees from its consumer business, as GenomeWeb reports. It says that this represents about 14 percent of the overall 23andMe workforce.

CNBC traces this move to a decline in sales, and CEO Anne Wojcicki tells it that she was surprised by the turn in the market but notes privacy concerns could be a factor as could fears of a wider economic downturn. "This has been slow and painful for us," Wojcicki tells CNBC.

The Verge reports that other genetic testing companies have also noted a shrinking market. Illumina reported last year, it says, that there had been a decline in the direct-to-consumer genetic testing space and that Veritas Genomics recently paused its US operations and laid off staff. GenomeWeb also notes that Helix had layoffs and shifted its focus to population genomics partnerships.

Privacy has also been an increasing concern for the field, as people have become worried about how their data could be used, CNBC adds. 

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.